Previous 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Chamath Palihapitiya’s Social Capital Suvretta Holdings III (NASDAQ: DNAC ) announced this morning it is merging with medical technology company ProKidney in a $2.6 billion deal. This move seems to have inves...
ProKidney offers a first-of-its-kind, patented disease-modifying autologous cell therapy for treatment of chronic kidney disease (“CKD”) Lead product candidate, REACT®, has potential to slow, stabilize, and even reverse decline in kidney function, dela...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tech firebrand Chamath Palihapitiya is still looking for merger candidates for two of his six blank-check companies. But that hasn’t stopped the ace investor from filing for four more special purpose acquisition comp...
In the US IPO market’s busiest week since 2004, 19 IPOs raised nearly $10 billion, led by Chinese ride-hailing giant DiDi Global. Cybersecurity platform SentinelOne (S) upsized and priced above the upwardly revised range to raise $1.2 billion at a $10.6 billion market cap....
News, Short Squeeze, Breakout and More Instantly...
Social Capital Suvretta Holdings Corp. III Company Name:
DNAC Stock Symbol:
NASDAQ Market:
Social Capital Suvretta Holdings Corp. III (“SCS”) today announced that it will reconvene the Extraordinary General Meeting of its shareholders to vote on the Business Combination Agreement, dated as of January 18, 2022, by and between SCS and ProKidney LP, a limited partn...
WINSTON-SALEM, N.C., June 23, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on the treatment of chronic kidney disease (CKD) and the prevention of end-stage renal disease (ESRD) requiring dialysis or transplant, today publi...
WINSTON-SALEM, N.C., June 15, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (“ProKidney”), a leading clinical-stage cellular therapeutics company focused on therapies for chronic kidney disease (“CKD”), today announced an update on manufacturing efficiency and supply cha...